AtriCure Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +20.8% | +19.5% | +12.6% | +15.4% | +14.5% | -10.5% | +32.8% | +20.4% | +20.8% | +16.5% | +14.9% | |
| – | +16.3% | +19.3% | +10.3% | +12.3% | +10.9% | -5.4% | +19.7% | +23.3% | +17.1% | +19.1% | +16.1% | |
| – | +22.6% | +19.6% | +13.6% | +16.6% | +15.8% | -12.3% | +37.9% | +19.5% | +22.1% | +15.7% | +14.4% | |
| – | +38.4% | +39.2% | -4.7% | +1.7% | +18.7% | +4.5% | +12.6% | +18.2% | +28.9% | +30.1% | -6.2% | |
| – | +27.7% | +13.4% | +9.9% | +10.7% | +25.2% | -7.2% | -86.8% | +1,065.2% | +9.5% | +15.1% | +6.7% | |
| – | +29.8% | +18.9% | +6.3% | +8.7% | +23.9% | -4.9% | -22.2% | +91.6% | +13.3% | +18.5% | +3.5% | |
| – | – | – | – | – | – | – | – | -177.3% | – | – | – | |
| – | -4.3% | +516.8% | +25.7% | +103.5% | -10.8% | +18.8% | +0.7% | +1.4% | +38.9% | -7.5% | -8.3% | |
| – | – | – | – | – | – | – | – | -191.7% | – | – | – | |
| – | +9.1% | +11.1% | -65.0% | +1,514.3% | -11.9% | -42.7% | +64.9% | +42.6% | +120.5% | +73.3% | +25.5% | |
| – | – | – | – | – | – | – | – | -192.6% | – | – | – | |
| – | – | – | – | – | – | – | – | -147.1% | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.